GlassScriptPhysician profile
April Mikes
NPI 1801230354
$14,784.67
in general payments reported to CMS, 2019-2025
25 companies · $1,067 in 2025
The $1,067 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $106 · 2021: $331 · 2022: $13K · 2023: $365 · 2024: $261 · 2025: $1,067.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $877 · Travel and Lodging: $730 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $877.17 |
| Travel and Lodging | $730.49 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,971.45 | 2022-2025 | |
| Abbvie INC. | $315.16 | 2019-2023 | |
| Astellas Pharma US INC | $302.80 | 2022-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $221.50 | 2019-2025 | Slynd |
| Sumitomo Pharma America, INC. | $180.53 | 2024-2025 | Gemtesa |
| Organon LLC | $146.19 | 2021-2025 | Nexplanon |
| Biogen, INC. | $106.17 | 2025 | Zurzuvae |
| Ethicon US, LLC | $87.63 | 2019-2025 | Stratafix, Dermabond Prineo, Vistaseal |
| Pfizer INC. | $53.33 | 2021-2024 | |
| Hologic Sales and Service, LLC | $46.74 | 2021 | |
| Amag Pharmaceuticals, INC. | $39.71 | 2019-2021 | |
| Mycovia Pharmaceuticals, INC. | $36.12 | 2023 | Vivjoa |
| Merck Sharp & Dohme LLC | $35.41 | 2020-2021 | |
| Coopersurgical, INC. | $29.49 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $27.80 | 2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $27.09 | 2022-2023 | Twirla |
| Therapeuticsmd, INC. | $26.00 | 2020-2021 | |
| Avion Pharmaceuticals | $25.44 | 2020-2022 | |
| Shield Therapeutics INC | $21.03 | 2023 | |
| Millicent US INC | $19.66 | 2024 | Intrarosa |
| Duchesnay USA Incorporated | $16.21 | 2019 | |
| Evofem Biosciences, INC. | $15.47 | 2021 | |
| Tela Bio, INC. | $11.55 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.36 | 2019 | |
| Allergan, INC. | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Mikes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.